Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection

Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, launches a number of events to raise awareness for the importance of early detection of colorectal cancer with physicians and medical professionals, but also with patients, their families, caregivers and the general public in Germany.

Scroll to Top